Fertility: The ovaries play a key role in reproductive decline, new research shows
A woman’s fertility usually begins to decline in her mid-30s. This means the chances of becoming pregnant decreases drastically each month.
Powered by WPeMatico
Global survey reveals obesity hidden in normal BMI contributing to metabolic disorders
A multinational team of researchers has discovered that over 20% of adults with a normal BMI range experience levels of abdominal obesity that puts them at higher risk of hypertension, diabetes, high total cholesterol, and elevated triglycerides.
Powered by WPeMatico
Invisible wounds of the Ohio tornadoes: The mental health crisis after the storm
In early 2024, central Ohio faced one of its worst tornado seasons in history—66 confirmed tornadoes in less than five months.
Powered by WPeMatico
UP hospital, doctor cleared of negligence charges after 25-year legal battle
The National Consumer Disputes Redressal Commission (NCDRC) recently exonerated an UP-based hospital and doctor from charges of medical negligence while treating an injured patient, who died after treatment.
Even though the State Consumer Court had held the hospital and the treating doctor liable, after considering the evidence submitted, including the treatment documents, the Apex Consumer Court observed that there was no medical negligence.
For more details, check out the full story on the link mentioned below:
After 25 years long battle: Hospital, doctor finally get relief from medical negligence charges
Powered by WPeMatico
MCC releases NEET 2025 Round 3 results, revises counselling schedule again
The Medical Counselling Committee (MCC) has further revised the schedule of the National Eligibility and Entrance Test Undergraduate (NEET UG) 3rd and Stray Vacancy Round Counselling for the academic year 2025 for the All India Quota and State Quota seats.
The revised schedule has been released on the official MCC website.
As per the revised schedule, candidates can report to their seats from 24th October 2025 for round 3 admissions and stray vacancy round begins from November 4th.
For more details, check out the full story on the link mentioned below:
MCC NEET 2025 counselling: Round 3 results OUT, Schedule revised again- check new dates
Powered by WPeMatico
Syngene International plans to add bioconjugation suite for end-to-end Antibody-Drug conjugates development
Mumbai: Syngene International, a global contract research, development and manufacturing organization (CRDMO), is adding a GMP bioconjugation suite at its commercial biologics facility [Unit 3] in Bengaluru.
With this new capability, Syngene will offer fully integrated, end-to-end services for antibody-drug conjugates (ADCs) – from discovery through to GMP manufacturing.
The OEB-5 rated suite will accelerate ADC development timelines by enabling both Monoclonal Antibodies (mAb) production and GMP bioconjugation at a single site, complementing Syngene’s existing commercial capabilities in payload and linker manufacturing. Expected to be operational within this financial year, the conjugation facility will also support a range of advanced conjugates and related modalities. These services are further strengthened by collocated analytical and bioanalytical capabilities, ensuring seamless integration across the development lifecycle.
“The discovery and development of ADCs is complex, often involving multiple vendors and geographically dispersed sites, which adds substantial supply chain complexity and potential delays,” said Alex Del Priore, Head – LM CDMO, Syngene International. “By integrating bioconjugation capabilities with our commercial-scale biologics, payload, and linker production units in Bengaluru, we can significantly compress development timelines and offer a unique, end-to-end pathway from early discovery through to GMP manufacturing.” he added.
Syngene is scaling its capabilities to support clinical programs and plans to develop commercial-scale capabilities in the future.
Additionally, the laboratories will offer process development, analytical characterization, and scale-up for both early- and late-stage programs. This addition will further enhance Syngene’s ability to serve biotech and biopharma clients seeking agile, science-driven partners for their ADC programs.
Syngene will be present at CPHI Frankfurt, Ground Level, Hall Number 6, Booth Number C66.
Read also: Syngene International names Chethan Yogesh as Company Secretary, Compliance Officer
Syngene International Ltd. is an integrated research, development, and manufacturing services company serving the global pharmaceutical, biotechnology, nutrition, animal health, consumer goods, and specialty chemical sectors.
Powered by WPeMatico
NEET PG 2025: 49,907 MD, MS, PG Diploma seats available- NMC seat matrix released
Altogether 49,907 postgraduate medical seats across 68 specialities are available, revealed the seat matrix for the National Eligibility-Entrance Test Postgraduate (NEET PG) 2025 counselling, recently released by the National Medical Commission (NMC).
The updated NEET PG seat matrix has been notified by the Gujarat Admission Committee for Professional Post Graduate Medical Courses (ACPPGMEC) on its official website.
For more details, check out the full story on the link mentioned below:
49,907 MD, MS, PG Diploma seats available for NEET PG 2025 counselling- NMC seat matrix released
Powered by WPeMatico
CDSCO Panel Rejects Troikaa Pharma’s High-Strength Paracetamol Injection Citing Safety Concerns
New Delhi: Ahmedabad-based pharma firm, Troikaa Pharmaceuticals Limited has been refused approval by the Subject Expert Committee (SEC) under the Central Drugs Standard Control Organization (CDSCO) for its proposed Paracetamol Injection 1000 mg/4 ml.
The decision was made during the committee’s 8th meeting held on September 17, 2025, at CDSCO headquarters in New Delhi.
The firm had appeared before the committee to provide clarifications on observations made during the SEC meeting dated June 24, 2025, regarding its earlier submission. Troikaa Pharmaceuticals proposed the Paracetamol Injection 1000 mg/4 ml as a new high-strength parenteral formulation intended to provide rapid pain and fever relief, positioning it as an alternative to the existing Paracetamol solution for infusion 10 mg/ml (1000 mg/100 ml).
After reviewing the company’s submission and clarifications, the SEC (Analgesic & Rheumatology), following detailed deliberation, opined that:
a) The applied indication can be appropriately addressed with the currently available Paracetamol solution for infusion 10 mg/ml (1000 mg/100 ml) formulation.
b) There is no superiority or additional therapeutic benefit with Paracetamol 1000 mg/4 ml injection over the existing Paracetamol infusion 10 mg/ml (1000 mg/100 ml) formulation.
c) As per the product information, if the diluted solution is not used within 8 minutes, crystallization may occur, posing an additional risk for patient safety.
d) The Paracetamol 1000 mg/4 ml injection demonstrated significantly higher Cmax and AUC (0–t/0–∞) compared to the Paracetamol intravenous infusion (10 mg/ml, 1000 mg/100 ml), which may lead to liver toxicity.
Based on these findings, the SEC did not recommend the grant of permission for the manufacture and marketing of Paracetamol Injection 1000 mg/4 ml, concluding that the proposed product offers no additional clinical advantage and poses potential safety risks.
Paracetamol (acetaminophen) is a commonly used analgesic and antipyretic drug prescribed for mild to moderate pain and fever. Troikaa Pharmaceuticals Limited specializes in developing advanced injectable drug delivery systems and has a strong portfolio in pain management formulations.
Powered by WPeMatico
Health Bulletin 25/October/2025
Here are the top health stories for the day:
NEET PG 2025: 49,907 MD, MS, PG Diploma seats available- NMC seat matrix released
Altogether 49,907 postgraduate medical seats across 68 specialities are available, revealed the seat matrix for the National Eligibility-Entrance Test Postgraduate (NEET PG) 2025 counselling, recently released by the National Medical Commission (NMC).
The updated NEET PG seat matrix has been notified by the Gujarat Admission Committee for Professional Post Graduate Medical Courses (ACPPGMEC) on its official website.
For more details, check out the full story on the link mentioned below:
49,907 MD, MS, PG Diploma seats available for NEET PG 2025 counselling- NMC seat matrix released
MCC releases NEET 2025 Round 3 results, revises counselling schedule again
The Medical Counselling Committee (MCC) has further revised the schedule of the National Eligibility and Entrance Test Undergraduate (NEET UG) 3rd and Stray Vacancy Round Counselling for the academic year 2025 for the All India Quota and State Quota seats.
The revised schedule has been released on the official MCC website.
As per the revised schedule, candidates can report to their seats from 24th October 2025 for round 3 admissions and stray vacancy round begins from November 4th.
For more details, check out the full story on the link mentioned below:
MCC NEET 2025 counselling: Round 3 results OUT, Schedule revised again- check new dates
NMC delays action against 30 doctors accused in pharma freebies case
Nearly 10 months have passed since the Department of Pharmaceuticals (DoP) recommended disciplinary action against 30 doctors accused of accepting pharma-sponsored foreign trips worth Rs 1.91 crore to Monaco and Paris, the National Medical Commission (NMC) is yet to take a decision on the matter.
The case continues to remain under consideration with the Ethics and Medical Registration Board (EMRB), which is currently facing vacancies in key positions.
For more details, check out the full story on the link mentioned below:
NMC yet to take action against 30 doctors in pharma freebies case
UP hospital, doctor cleared of negligence charges after 25-year legal battle
The National Consumer Disputes Redressal Commission (NCDRC) recently exonerated an UP-based hospital and doctor from charges of medical negligence while treating an injured patient, who died after treatment.
Even though the State Consumer Court had held the hospital and the treating doctor liable, after considering the evidence submitted, including the treatment documents, the Apex Consumer Court observed that there was no medical negligence.
For more details, check out the full story on the link mentioned below:
After 25 years long battle: Hospital, doctor finally get relief from medical negligence charges
Powered by WPeMatico
Patna’s Khan Sir Hospital nears completion, promises affordable healthcare
Patna: A state-of-the-art hospital in Patna, spearheaded by renowned teacher and social reformer Khan Sir, is nearing completion, with its dialysis centre and operation theatre fully ready to serve patients. The facility aims to provide quality healthcare affordable and accessible, especially for the poor.
Khan Sir, celebrated for his unique teaching methods and dedication to public welfare, personally inspected the hospital this week. During his visit, he meticulously examined the dialysis machines, surgical equipment, and patient facilities, directing staff to implement immediate improvements wherever necessary.
“Our aim is to make healthcare accessible to everyone. Treatment here will be cheaper than in government hospitals,” Khan Sir stated. The hospital, designed with modern amenities including a blood bank, dialysis unit, and cancer treatment facilities, aims to set new standards for affordable medical care in Bihar.
Redesigned Operation Theatre
The operation theatre underwent complete reconstruction after Khan Sir identified flaws in the initial layout. The original design used glossy tiles, which he deemed unsafe for surgical environments due to bacterial growth in the tile joints.
Also Read:1500 New Hospitals Coming to Rural Areas of Bihar Soon
According to the Patna Press, recalling the decision in one of his classes, Khan Sir explained, “When two tiles join, their fine gap becomes a home for bacteria, viruses, and fungus. Even a mustard seed could hold thousands of them.” To ensure hygiene, the hospital replaced tiles with special medical-grade anti-infection mats that resemble marble but are safer for surgical use.
Fully Functional Dialysis Centre
The hospital’s dialysis centre is now fully functional, featuring advanced machinery and strict infection control measures. Khan Sir personally tested the equipment under the supervision of medical professionals.
Speaking to the Patna Press, sources close to the project suggest that the hospital’s inauguration could take place soon, though the exact location remains undisclosed.
Also Read:2000-bed state-of-the-art hospital to come up in Chandigarh
The facility reflects Khan Sir’s long-standing mission to make quality healthcare accessible to all, particularly for the economically disadvantaged.
This new hospital marks a significant step in bridging the gap between affordable healthcare and modern medical facilities in Bihar, embodying Khan Sir’s vision of social reform beyond education.
Powered by WPeMatico